About Wesley Ryan, MD
Dr. Ryan is a practicing psychiatrist based in Los Angeles specializing in both addiction and general psychiatry. He has trained and practiced in various clinical and research settings across Los Angeles and Seattle including the UCLA Neuropsychiatric Institute, Olive View-UCLA Medical Center, University of Washington, Harborview Medical Center, several Veteran Affairs medical centers, Kaiser West Los Angeles, Loyola Marymount University, St. Joseph Center, Ocean Park Community Center, Venice Family Clinic, as well as his own private practice. He has extensive and diverse training in state-of-the-art mental health and addiction treatment, attending to individuals with mental health needs, substance abuse issues, and both (dual diagnosis). Additionally, he has worked in various research settings, accumulating multiple published articles and presentations on such topics as ketamine for treatment resistant depression, cannabis, psychedelics, club drugs, hallucinogens, and addiction.
Through his diverse experiences and training in both pharmacology and psychotherapy, Dr. Ryan's approach integrates individually tailored medication management, therapeutic interventions, and lifestyle changes with novel treatment options, in an empathic, non-judgmental, safe space, effectively helping clients find their motivation for change and improvement. He has applied these principles in those with PTSD and other anxiety disorders, depression, bipolar disorder, psychotic disorders, and substance use disorders. He is well versed in psychodynamic psychotherapy and particularly enjoys working with individuals in helping them achieve meaningful personal growth.
Dr. Ryan is a graduate of University of California, Davis and went on to complete medical school at the University of California, Irvine. He is board certified by the American Board of Psychiatry and Neurology (ABPN) in both general psychiatry as well as addiction psychiatry. He completed psychiatry residency at the UCLA-San Fernando Valley Program and an addiction psychiatry fellowship at the University of Washington.
Some of his scholarly work includes:
Ryan WC. Ketamine Science. Psychedelic Science 2017, Ketamine: Science, Therapy, and Transformation workshop; 2017, April 24; Oakland, CA. [ video pending ]
Ryan WC, Marta CJ, Koek RJ (2016). Ketamine and depression: a review in The Ketamine Papers--Science, Therapy and Transformation. Santa Cruz, CA: Multidisciplinary Association for Psychedelic Studies. [ order the book via the publisher, or via amazon ]
Ryan WC, Marta CJ. Ketamine for depression, a prescription psychedelic. Aware Project Psychedelic Awareness Salon; 2016, August 17th; Culver City, CA. [ full video of the presentation ]
Marta CJ, Ryan WC, Kopelowicz A, Koek RJ. Mania following use of ibogaine: a case series. American Journal on Addictions. 2015;24(3):203-5. [ abstract ]
Ryan W. Hallucinogens and addiction. 16th Annual Fundamentals of Addiction Medicine Course; 2015, March 6; Marysville, WA.
Ryan W. Research for prescription Cannabis is needed [letter to the editor]. Current Psychiatry. 2014;13(11):33-34. [ full text ]
Marta C, Ryan W, Shachet B, Mithoefer M. Comparison of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in treatment of combat and civilian post-traumatic stress disorder. Poster session presented at: 66th Annual Institute on Psychiatric Services; 2014, October 31 – November 2; San Francisco, CA.
Ryan W, Marta CJ, May D. Medical and psychiatric issues in a festival population. Zendo Project Volunteer Training; 2014, August 26; Black Rock City, NV.
Ryan W, Koek R. Ketamine as a rapid acting antidepressant. California-Wide Psychiatry Research Resident Retreat, UCSF Psychiatry Department; 2013, May 17; San Francisco, CA.